A recent study published in the Indian Journal of Psychiatry in June 2026 highlights intermittent theta burst stimulation (iTBS) as a rapid, non-invasive breakthrough for schizophrenia's notoriously stubborn negative symptoms. Antipsychotics effectively manage positive schizophrenia symptoms, but debilitating negative symptoms remain a significant therapeutic challenge. Given the inconsistent results of conventional repetitive transcranial magnetic stimulation (rTMS), Dr. Nand Kumar and colleagues at AIIMS, New Delhi, systematically reviewed the safety and efficacy of the shorter intermittent theta burst stimulation (iTBS) protocol to address this clinical gap. Therefore, the researchers reviewed nine randomized controlled trials (n=440; ages 18–60 years) evaluating 10 to 40 sessions of intermittent theta burst stimulation (iTBS). ReferenceKumar N, Hans G, Madiha M, Prasad S, Narnoli S. Safety and efficacy of intermittent theta burst stimulation (iTBS) in schizophrenia with predominant negative symptoms: A brief review.